Compare FUNC & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FUNC | EMBC |
|---|---|---|
| Founded | 1900 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 256.1M | 207.1M |
| IPO Year | 2012 | 2021 |
| Metric | FUNC | EMBC |
|---|---|---|
| Price | $44.03 | $3.24 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $18.50 |
| AVG Volume (30 Days) | 24.1K | ★ 2.5M |
| Earning Date | 04-20-2026 | 05-05-2026 |
| Dividend Yield | 2.80% | ★ 6.88% |
| EPS Growth | 19.68 | ★ 20.90 |
| EPS | ★ 1.03 | 0.67 |
| Revenue | ★ $18,426,000.00 | N/A |
| Revenue This Year | $13.05 | $1.17 |
| Revenue Next Year | $6.56 | N/A |
| P/E Ratio | $42.62 | ★ $4.75 |
| Revenue Growth | ★ 4.01 | N/A |
| 52 Week Low | $31.80 | $2.77 |
| 52 Week High | $46.30 | $15.55 |
| Indicator | FUNC | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 60.02 | 42.29 |
| Support Level | $36.68 | $3.01 |
| Resistance Level | $46.30 | $3.48 |
| Average True Range (ATR) | 1.49 | 0.17 |
| MACD | -0.16 | 0.08 |
| Stochastic Oscillator | 56.74 | 46.94 |
First United Corp is active in the financial services domain. The scope of its offering includes checking, savings, money market deposit accounts and certificates of deposit, business loans, personal loans, mortgage loans and lines of credit extended to both individuals and businesses. The bank also provides residential real estate construction loans to builders and individuals for single-family dwellings. The company's reportable operating segments include community banking and wealth management. The company generates the majority of its revenue from the Community Banking segment, which is engaged in delivering financial products and services, including various loan and deposit products, to consumer, business, and not-for-profit customers.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.